EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for SRRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.8414
March 31, 2026 -0.829
December 31, 2025 -0.8824
September 30, 2025 -0.8988
June 30, 2025 -0.9763
March 31, 2025 -0.6681
December 31, 2024 -0.7083
September 30, 2024 -0.6644
June 30, 2024 -0.6043
March 31, 2024 -0.5929
December 31, 2023 -0.6071
September 30, 2023 -0.5255
June 30, 2023 -0.4734
March 31, 2023 -0.4946
December 31, 2022 -0.7597
September 30, 2022 -0.5457
June 30, 2022 -1.057
March 31, 2022 -0.2122
December 31, 2021 -1.02
Date Value
September 30, 2021 -1.022
June 30, 2021 -0.8394
March 31, 2021 -0.7606
December 31, 2020 -0.7944
September 30, 2020 -0.7912
June 30, 2020 -0.6494
March 31, 2020 -0.5781
December 31, 2019 -0.3884
September 30, 2019 -0.5524
June 30, 2019 -0.4832
March 31, 2019 -0.4202
December 31, 2018 -0.5708
September 30, 2018 -0.4427
June 30, 2018 -1.39
March 31, 2018 -0.3522
December 31, 2017 -0.335
September 30, 2017 -0.2349
June 30, 2017 -0.2329
March 31, 2017 -0.1874

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
Anika Therapeutics, Inc. 0.2412
BioCryst Pharmaceuticals, Inc. 0.2957
Imunon, Inc. -0.5412

EPS Diluted (Quarterly) Related Metrics